Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact

Sleuthing out the cellular source of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most frequently diagnosed type of liver cancer and the third leading cause of cancer deaths worldwide.  Chronic liver disease, which can be triggered by viral hepatitis, cirrhosis, and exposure to hepatotoxins, can lead to liver damage and promote HCC carcinogenesis.    Although the pathophysiological steps that lead to the development of HCC are relatively well characterized, the cellular source of HCC is not currently known.  Owing to their role in the regeneration of liver tissue, hepatocytes, liver progenitor/biliary cells, and hepatic stellate cells (HSCs) have each been suggested as the cellular origin of HCC.  Xueru Mu, Regina Español-Suñer, and colleagues at Columbia University and Université catholique de Louvain, respectively, examined the ability of each of these three cell types to form HCC lesions in vivo.  Using cell lineage tracing in several genotoxic and non-genotoxic mouse models of HCC, the authors demonstrated that HCC tumors do not arise from progenitor/biliary cells nor do they arise from HSCs.  Instead, over 95% of HCC tumors that formed in these mouse models were determined to be of hepatocyte origin.  Additionally, the authors showed that the progenitor-like characteristics of many mouse HCCs are not a consequence of progenitor/biliary cell origin but, instead, are a result of dedifferentiation of hepatocytes during the tumorigenic process.  This systematic study clearly indicates a hepatocyte origin for most, if not all, of the HCC tumors in these mouse models.  Further studies should be undertaken to determine if HCC in humans follows the same pattern.  The accompanying image shows a photograph and fluorescent image (hepatocyte-restricted ZsGreen) of a whole liver from the Mdr2 knockout mouse model of HCC.  Note that the large tumor on the surface of the liver is ZsGreen positive indicating hepatocyte origin.

Published September 8, 2015, by Brian P. Head

Scientific Show StopperOncology

Related articles

Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment
Xueru Mu, … , Isabelle A. Leclercq, Robert F. Schwabe
Xueru Mu, … , Isabelle A. Leclercq, Robert F. Schwabe
Published September 8, 2015
Citation Information: J Clin Invest. 2015;125(10):3891-3903. https://doi.org/10.1172/JCI77995.
View: Text | PDF
Research Article Oncology

Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment

  • Text
  • PDF
Abstract

In many organs, including the intestine and skin, cancers originate from cells of the stem or progenitor compartment. Despite its nomenclature, the cellular origin of hepatocellular carcinoma (HCC) remains elusive. In contrast to most organs, the liver lacks a defined stem cell population for organ maintenance. Previous studies suggest that both hepatocytes and facultative progenitor cells within the biliary compartment are capable of generating HCC. As HCCs with a progenitor signature carry a worse prognosis, understanding the origin of HCC is of clinical relevance. Here, we used complementary fate-tracing approaches to label the progenitor/biliary compartment and hepatocytes in murine hepatocarcinogenesis. In genotoxic and genetic models, HCCs arose exclusively from hepatocytes but never from the progenitor/biliary compartment. Cytokeratin 19–, A6- and α-fetoprotein–positive cells within tumors were hepatocyte derived. In summary, hepatocytes represent the cell of origin for HCC in mice, and a progenitor signature does not reflect progenitor origin, but dedifferentiation of hepatocyte-derived tumor cells.

Authors

Xueru Mu, Regina Español-Suñer, Ingmar Mederacke, Silvia Affò, Rita Manco, Christine Sempoux, Frédéric P. Lemaigre, Arlind Adili, Detian Yuan, Achim Weber, Kristian Unger, Mathias Heikenwälder, Isabelle A. Leclercq, Robert F. Schwabe

×
Advertisement
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts